EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy

Taylor Carmichael, The Motley Fool
·2-min read
EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy
EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy

The European Commission has joined the Food and Drug Administration in accepting Zejula as a front-line therapy.